Evoke plc (LON:EVOK – Get Free Report) shares fell 10% during trading on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares changed hands during mid-day trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analyst Ratings Changes
Several research firms recently weighed in on EVOK. Jefferies Financial Group reissued a “buy” rating and set a GBX 140 ($1.81) price objective on shares of Evoke in a report on Monday, December 16th. Berenberg Bank cut their price target on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research note on Wednesday, December 4th.
Check Out Our Latest Report on Evoke
Evoke Trading Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last announced its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, equities research analysts expect that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insider Transactions at Evoke
In other news, insider Andrea Gisle Joosen bought 14,572 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was acquired at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). 27.00% of the stock is owned by corporate insiders.
About Evoke
Read More
- Five stocks we like better than Evoke
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- MarketBeat Week in Review – 03/24 – 03/28
- What is a support level?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- With Risk Tolerance, One Size Does Not Fit All
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.